Adrian Ochsenbein
Bern medical oncology chief whose lab targets leukaemia stem cells and CD70 signalling.
Overview
Adrian Ochsenbein is Chief Physician of Medical Oncology at Inselspital, Bern University Hospital, and a Director of the University Cancer Center Inselspital. His translational research investigates leukaemia stem cells and immune regulation, leading to the clinical development of the anti-CD70 antibody cusatuzumab in acute myeloid leukaemia. He combines a large clinical department with a laboratory programme in tumour immunology.
| Title | Journal | Year |
|---|---|---|
| Targeting CD70 with cusatuzumab eliminates acute myeloid leukemia stem cells in patients treated with hypomethylating agents | Nature Medicine | 2020 |
Pages like this
not linked directly; found by shared links- PersonBrian Huntly
Shares Acute myeloid leukaemia and the tags leadership, clinician-scientist, leukaemia.
- PersonKonstanze Döhner
Shares Acute myeloid leukaemia and the tags leadership, clinician-scientist, leukaemia.
- PersonDaniel M. Aebersold
Shares Inselspital, Bern University Hospital / University Cancer Center Inselspital and the tags leadership, clinician-scientist.
- PersonHubert Serve
Shares Acute myeloid leukaemia and the tags leadership, clinician-scientist, leukaemia.
- PersonThomas Kindler
Shares Acute myeloid leukaemia and the tags leadership, clinician-scientist, leukaemia.
- PersonJürgen Kuball
Shares Acute myeloid leukaemia and the tags leadership, clinician-scientist, immunotherapy.
- PersonMarco Vignetti
Shares Acute myeloid leukaemia and the tags leadership, clinician-scientist, leukaemia.
- PersonMartin Bornhäuser
Shares Acute myeloid leukaemia and the tags leadership, clinician-scientist, leukaemia.